Bioregenx (BRGX) Cash & Current Investments (2021 - 2026)
Bioregenx (BRGX) recorded quarterly Cash & Current Investments of $45806.0 in Q1 2026, down 33.98% quarter-over-quarter from $69383.0 in Q4 2025, and down 45.22% on a YoY basis from $83625.0 in Q1 2025.
Bioregenx (BRGX) Cash & Current Investments (2021 - 2026) Analysis & Trends
Bioregenx's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $45806.0 for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 45.22% year-over-year to $45806.0; the TTM figure through Mar 2026 stood at $45806.0 (down 45.22% YoY), while the FY2025 annual figure was $69383.0, up 18.8% from the prior year.
- Cash & Current Investments was $45806.0 for Q1 2026 at Bioregenx, down from $69383.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $125402.0 in Q4 2023 to a low of $676.0 in Q4 2022.
- Historically, Cash & Current Investments has averaged $48412.9 across 5 years, with a median of $46947.0 in 2025.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments plunged 97.22% in 2022, then soared 18450.59% in 2023.
- A 5-year view of Cash & Current Investments shows it stood at $676.0 in 2022, then jumped by 18450.59% to $125402.0 in 2023, then plunged by 53.43% to $58404.0 in 2024, then grew by 18.8% to $69383.0 in 2025, then slumped by 33.98% to $45806.0 in 2026.
- The last three Cash & Current Investments figures came in at $45806.0 (Q1 2026), $69383.0 (Q4 2025), and $46947.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 7.31 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 888.80 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 265.37 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 315.87 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 539.85 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 748.60 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 158.93 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 419.52 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 174.90 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | 45,806.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45,806.00 |
| Dec 31, 2025 | 69,383.00 |
| Sep 30, 2025 | 46,947.00 |
| Jun 30, 2025 | 46,456.00 |
| Mar 31, 2025 | 83,625.00 |
| Dec 31, 2024 | 58,404.00 |
| Sep 30, 2024 | 70,081.00 |
| Jun 30, 2024 | 57,395.00 |
| Mar 31, 2024 | 114,158.00 |
| Dec 31, 2023 | 125,402.00 |
| Sep 30, 2023 | 758.00 |
| Dec 31, 2022 | 676.00 |
| Sep 30, 2022 | 1,541.00 |
| Jun 30, 2022 | 2,123.00 |
| Mar 31, 2022 | 3,438.00 |
| Dec 31, 2021 | 24,358.00 |